Current Opinion in Organ Transplantation was launched in 1996. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of organ transplantation is divided into 18 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Editor-in-Chief, Associate Editors and Section Editors for this issue.
Linda S. Sher
Dr Sher is Professor of Clinical Surgery and Director of Clinical Research in the Division of Hepatobiliary Surgery and Abdominal Organ Transplantation at Keck School of Medicine, University of Southern California (USC), USA. After completing her medical school education and surgical residency at Mount Sinai School of Medicine in New York, USA, Dr Sher undertook her fellowship training in Liver and Kidney Transplantation at the University of Pittsburgh, USA. After completing her fellowship in 1988, Dr Sher was involved in the establishment of two liver transplant programs in Los Angeles prior to joining the USC program in 2001. Dr Sher has participated in and overseen over 50 research projects and is currently very active in the development of the clinical and basic science research components of the USC Abdominal Organ Transplantation Program. She has numerous publications on immunosuppression, chronic rejection, disease recurrence, infection, and hepatobiliary surgery.
Dr Sher is one of the original editors of Current Opinion in Organ Transplantation and has endeavored over the years to provide the reader with an up to date overview of the entire field of organ transplantation.
Josep M. Grinyó
Josep M. Grinyó, MD, PhD, is the Chief of Nephrology at the University Hospital of Bellvitge, Spain, and Full Professor of Medicine at the University of Barcelona, Department of Medicine, Spain. Dr Grinyó's research work on renal transplantation has been focused on immunosuppression, ischemia-reperfusion injury and chronic allograft damage in the clinical setting and in experimental animal models.
Josep Grinyó is Associate Editor of the Current Opinion in Transplantation, Transplant International, Consulting Editor of the American Journal of Transplantation and member of the editorial boards of Transplantation and Kidney International.
Josep Grinyó has authored or co-authored over 300 articles and given more than 200 invited lectures.
Jerzy W. Kupiec-Weglinski
Dr Kupiec-Weglinski is the Director of Dumont-University of California, Los Angeles (UCLA) Transplant Research Laboratories in Los Angeles, USA. He is Professor of Surgery and Pathology, and Vice-Chairman, Department of Surgery (Research), at the David Geffen School of Medicine at UCLA. He holds the Joan S. and Ralph N. Goldwyn Endowed Chair in Transplantation Research. Dr Kupiec-Weglinski's interests focus on the immunobiology of organ ischemia and reperfusion injury, host sensitization, and tolerance induction in transplant recipients. He has authored over 400 papers. His research for the last 28 years has been funded by National Institute of Health (NIH). He served as standing member of the Transplantation, Tolerance and Tumor Immunology (TTT) NIH Study Section, as member of the board of directors of American Society of Transplantation, and recipient of AST/Astellas Established Investigator Award in Basic Transplant Research. He holds the Honorary Doctorate (“Honoris Causa”) from Medical Academy in Warsaw, and is the Foreign Member of Polish Academy of Sciences.
Dr Paolo Cravedi, MD, PhD, is an Assistant Professor in the Division of Nephrology in the Department of Medicine. Dr. Paolo Cravedi is a scientist physician with a strong interest in kidney transplantation and autoimmune glomerular diseases. During his clinical training as nephrologist in Italy, he designed clinical research studies in kidney transplant recipients and in individuals with renal diseases aimed at prolonging survival of the graft or the native kidneys, respectively. His studies have contributed to defining the organ allocation system currently used in many countries around the world.
He subsequently completed his postdoctoral training at the Icahn School of Medicine at Mount Sinai, where he identified unanticipated immune effects of erythropoietin.
Dr Aaron Ahearn is Assistant Professor of Surgery at Keck Medical Center of USC and associate director of the Liver Transplant program. He has an active clinical practice as a liver, kidney, and pancreas transplant surgeon, including living donor liver transplant. His clinical research interests include expanding the use of living donor liver transplant, including bloodless liver transplant for Jehovah's witnesses and other patients unwilling to receive blood products, and studying the economic impact of liver donation. He also has an extensive background in Transplant Immunology, having previously studied the natural tolerance of Liver allografts in transgenic mouse models. He is an active member of ASTS and previously receive the ASTS Roche Laboratory Scientist Scholarship and the American Foundation for Donation and Transplantation Careers in Transplantation Award.
Prof. Uwe Heemann is a graduate from Bochum Medical University where he received his MD. He worked a fellow at the University Hospital Essen as well as at the Brigham Hospital in Boston. Currently he is Director of the Department of Nephrology, Klinikum rechts der Isar, Technical University Munich. Prof. Heemann is nationally and internationally recognized as leader in the field of kidney transplantation. He is a Past-President of the German Society of Transplantation, Member of the Board of Eurotransplant, Chair of the Kidney Advisory Committee of Eurotransplant and served as member of the DESCARTES group. His current activities focus on transplantation as well as the reduction of mortality in the field of dialysis.
Dr Heeman has published more than 350 articles cited in medline as well as a multitude of monographies and books, was principal investigator in multiple international and national trials and served as advisor for various scientific groups as well as pharmaceutical companies.
He has published in prestigious journals including Journal of Clinical Investigation, Kidney International, Transplantation, Circulation and Journal of the American Society of Nephrology.
In addition he serves on numerous international journals and lectures at universities around the world and has facilitated the careers of national and international fellows to high academic positions.